177 related articles for article (PubMed ID: 28585811)
1. Dinuclear Ru
Lenis-Rojas OA; Roma-Rodrigues C; Fernandes AR; Marques F; Pérez-Fernández D; Guerra-Varela J; Sánchez L; Vázquez-García D; López-Torres M; Fernández A; Fernández JJ
Inorg Chem; 2017 Jun; 56(12):7127-7144. PubMed ID: 28585811
[TBL] [Abstract][Full Text] [Related]
2. Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties.
Marcon G; Carotti S; Coronnello M; Messori L; Mini E; Orioli P; Mazzei T; Cinellu MA; Minghetti G
J Med Chem; 2002 Apr; 45(8):1672-7. PubMed ID: 11931621
[TBL] [Abstract][Full Text] [Related]
3. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
[TBL] [Abstract][Full Text] [Related]
4. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
Bugarcic T; Habtemariam A; Stepankova J; Heringova P; Kasparkova J; Deeth RJ; Johnstone RD; Prescimone A; Parkin A; Parsons S; Brabec V; Sadler PJ
Inorg Chem; 2008 Dec; 47(24):11470-86. PubMed ID: 19007206
[TBL] [Abstract][Full Text] [Related]
5. Non-covalent DNA binding and cytotoxicity of certain mixed-ligand ruthenium(II) complexes of 2,2'-dipyridylamine and diimines.
Rajendiran V; Murali M; Suresh E; Palaniandavar M; Periasamy VS; Akbarsha MA
Dalton Trans; 2008 Apr; (16):2157-70. PubMed ID: 18398542
[TBL] [Abstract][Full Text] [Related]
6. Half-sandwich Ru II[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: preparation, structural characterization and in vitro cytotoxic activity.
Bratsos I; Jedner S; Bergamo A; Sava G; Gianferrara T; Zangrando E; Alessio E
J Inorg Biochem; 2008; 102(5-6):1120-33. PubMed ID: 18279961
[TBL] [Abstract][Full Text] [Related]
7. Correlation between cytotoxicity and DNA binding of polypyridyl ruthenium complexes.
Nováková O; Kaspárková J; Vrána O; van Vliet PM; Reedijk J; Brabec V
Biochemistry; 1995 Sep; 34(38):12369-78. PubMed ID: 7547981
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands.
Habtemariam A; Melchart M; Fernandez R; Parsons S; Oswald ID; Parkin A; Fabbiani FP; Davidson JE; Dawson A; Aird RE; Jodrell DI; Sadler PJ
J Med Chem; 2006 Nov; 49(23):6858-68. PubMed ID: 17154516
[TBL] [Abstract][Full Text] [Related]
9. Ruthenium(II) sulfoxide-maltolato and -nitroimidazole complexes: synthesis and MTT assay.
Wu A; Kennedy DC; Patrick BO; James BR
Inorg Chem; 2003 Nov; 42(23):7579-86. PubMed ID: 14606854
[TBL] [Abstract][Full Text] [Related]
10. Complexes of cytotoxic chelators from the dipyridyl ketone isonicotinoyl hydrazone (HPKIH) analogues.
Bernhardt PV; Mattsson J; Richardson DR
Inorg Chem; 2006 Jan; 45(2):752-60. PubMed ID: 16411711
[TBL] [Abstract][Full Text] [Related]
11. Striking difference in antiproliferative activity of ruthenium- and osmium-nitrosyl complexes with azole heterocycles.
Büchel GE; Gavriluta A; Novak M; Meier SM; Jakupec MA; Cuzan O; Turta C; Tommasino JB; Jeanneau E; Novitchi G; Luneau D; Arion VB
Inorg Chem; 2013 Jun; 52(11):6273-85. PubMed ID: 23659478
[TBL] [Abstract][Full Text] [Related]
12. Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents.
Cini R; Tamasi G; Defazio S; Corsini M; Zanello P; Messori L; Marcon G; Piccioli F; Orioli P
Inorg Chem; 2003 Dec; 42(24):8038-52. PubMed ID: 14632524
[TBL] [Abstract][Full Text] [Related]
13. Cyclometalated ruthenium complexes overcome cisplatin resistance through PI3K/mTOR/Nrf2 signaling pathway.
Chen L; Yu W; Tang H; Zhang S; Wang J; Ouyang Q; Guo M; Zhu X; Huang Z; Chen J
Metallomics; 2024 Jan; 16(1):. PubMed ID: 38183290
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine).
Velders AH; Bergamo A; Alessio E; Zangrando E; Haasnoot JG; Casarsa C; Cocchietto M; Zorzet S; Sava G
J Med Chem; 2004 Feb; 47(5):1110-21. PubMed ID: 14971891
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, X-ray structure and in vitro antimycobacterial and antitumoral activities of Ru(II) phosphine/diimine complexes containing the "SpymMe2" ligand, SpymMe2=4,6-dimethyl-2-mercaptopyrimidine.
do Nascimento FB; Von Poelhsitz G; Pavan FR; Sato DN; Leite CQ; Selistre-de-Araújo HS; Ellena J; Castellano EE; Deflon VM; Batista AA
J Inorg Biochem; 2008 Sep; 102(9):1783-9. PubMed ID: 18614238
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization, and in vitro evaluation of novel ruthenium(II) eta6-arene imidazole complexes.
Vock CA; Scolaro C; Phillips AD; Scopelliti R; Sava G; Dyson PJ
J Med Chem; 2006 Sep; 49(18):5552-61. PubMed ID: 16942028
[TBL] [Abstract][Full Text] [Related]
17. Preparation, physicochemical properties and biological activity of copper(II) complexes with 6-(2-chlorobenzylamino)purine (HL1) or 6-(3-chlorobenzylamino)purine (HL2). The single-crystal X-ray structure of.
Trávnícek Z; Malon M; Sindelál Z; Dolezal K; Rolcík J; Krystof V; Strnad M; Marek J
J Inorg Biochem; 2001 Mar; 84(1-2):23-32. PubMed ID: 11330478
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization and assessment of the cytotoxic properties of cis and trans-[Pd(L)(2)Cl(2)] complexes involving 6-benzylamino-9-isopropylpurine derivatives.
Trávnícek Z; Szucová L; Popa I
J Inorg Biochem; 2007 Mar; 101(3):477-92. PubMed ID: 17208304
[TBL] [Abstract][Full Text] [Related]
19. Preliminary anti-cancer photodynamic therapeutic in vitro studies with mixed-metal binuclear ruthenium(II)-vanadium(IV) complexes.
Holder AA; Taylor P; Magnusen AR; Moffett ET; Meyer K; Hong Y; Ramsdale SE; Gordon M; Stubbs J; Seymour LA; Acharya D; Weber RT; Smith PF; Dismukes GC; Ji P; Menocal L; Bai F; Williams JL; Cropek DM; Jarrett WL
Dalton Trans; 2013 Sep; 42(33):11881-99. PubMed ID: 23783642
[TBL] [Abstract][Full Text] [Related]
20. Ruthenium polypyridyl complexes and their modes of interaction with DNA: is there a correlation between these interactions and the antitumor activity of the compounds?
Corral E; Hotze AC; den Dulk H; Leczkowska A; Rodger A; Hannon MJ; Reedijk J
J Biol Inorg Chem; 2009 Mar; 14(3):439-48. PubMed ID: 19085018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
